BTI
BSX icon

Blue Trust Inc’s Boston Scientific BSX Stock Holding History

Blue Trust Inc’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.1K Sell
1,431
-713
-33% -$38.7K ﹤0.01% 1265
2026
Q1 		$135K Sell
2,144
-269
-11% -$21.5K ﹤0.01% 901
2025
Q4 		$230K Sell
2,413
-233
-9% -$22.8K ﹤0.01% 724
2025
Q3 		$258K Buy
2,646
+623
+31% +$64.5K ﹤0.01% 712
2025
Q2 		$217K Sell
2,023
-2,977
-60% -$301K ﹤0.01% 740
2025
Q1 		$504K Buy
5,000
+575
+13% +$57.9K 0.01% 406
2024
Q4 		$395K Sell
4,425
-6,067
-58% -$534K 0.01% 445
2024
Q3 		$808K Buy
10,492
+5,017
+92% +$395K 0.01% 319
2024
Q2 		$375K Buy
5,475
+2,437
+80% +$178K 0.01% 485
2024
Q1 		$208K Buy
3,038
+1,553
+105% +$99.9K ﹤0.01% 483
2023
Q4 		$79K Buy
1,485
+142
+11% +$7.58K ﹤0.01% 777
2023
Q3 		$73K Buy
1,343
+78
+6% +$4.09K ﹤0.01% 718
2023
Q2 		$63K Sell
1,265
-911
-42% -$47.6K ﹤0.01% 624
2023
Q1 		$100K Buy
2,176
+43
+2% +$2.03K ﹤0.01% 765
2022
Q4 		$83K Sell
2,133
-92
-4% -$3.98K ﹤0.01% 727
2022
Q3 		$83K Sell
2,225
-400
-15% -$16K ﹤0.01% 595
2022
Q2 		$116K Buy
+2,625
New +$107K ﹤0.01% 455

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Blue Trust Inc's BSX Position: Q2 2026 in Review

Blue Trust Inc reduced its Boston Scientific (BSX) stake by 33% in Q2 2026, selling an estimated $38.7K and leaving 1,431 shares worth $61.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1265.

Blue Trust Inc first reported a position in BSX in Q2 2022 and has held it in 17 quarters since. The position peaked at $808K in Q3 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Blue Trust Inc held 1,431 shares of Boston Scientific worth $61.1K as of Q2 2026.
  • Blue Trust Inc sold 713 Boston Scientific shares in Q2 2026, an estimated $38.7K.
  • Boston Scientific made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1265 holding.
  • Blue Trust Inc first reported a position in Boston Scientific in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Boston Scientific position peaked at $808K in Q3 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.